Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EchoStar Corporation Common Stock (ECHO) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

EchoStar Corporation Common StockTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

EchoStar Corporation Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? EchoStar Corporation Common Stock trades at $87.14 (market cap $26.63B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: EchoStar Corporation Common Stock is far larger — about 3× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, EchoStar Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EchoStar Corporation Common Stock for 6 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

ECHOKYMR
Market Cap
$26.63B$8.87B
Volume
2,918,300779,107
Sector
MediaHealth
52-Week High
$141.80$127.31
52-Week Low
$66.93$55.80
Typical Hold Time
6 Days0 Days
Enterprise Value
$43.68B$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EchoStar Corporation Common Stock

ECHO trades at $91.56, down 3.72% over 24 hours, with a neutral technical signal and mixed earnings history including a significant Q2 2026 beat. The company reported a net loss of $14.50 billion in 2025, with negative cash flows, though revenue remains substantial at $15.00 billion. Recent news highlights institutional investments and a strategic partnership with United Airlines for in-flight streaming.

Analyst consensus is strongly bullish with a $134.00 price target, but high risks stem from persistent losses, negative cash flow, and the Hughes unit's bankruptcy. The stock's appeal hinges on turnaround execution and debt reduction efforts outweighing fundamental weaknesses.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ECHO

No sentiment data available yet.

KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About EchoStar Corporation Common Stock

EchoStar provides satellite communications and connectivity services. Its businesses support broadband, enterprise, government, and consumer communications needs.

Read more on ECHO →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →